Conference
1442P Safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving breast cancer resistant protein (BCRP) substrate chemotherapy agents
Authors
Schwartzberg L; Jordan K; Rapoport BL; Schnadig I; Chasen M; Arora S; Barbour S; Powers D; Navari R
Volume
27
Publisher
Elsevier
Publication Date
October 1, 2016
DOI
10.1093/annonc/mdw390.10
Conference proceedings
Annals of Oncology
ISSN
0923-7534